Effects of tris (2-carboxyethyl) phosphine hydrochloride treatment on porcine oocyte in vitro maturation and subsequent in vitro fertilized embryo developmental capacity.
Antioxidant
Embryonic development
In vitro maturation
Porcine oocyte
Tris (2-carboxyethyl) phosphine hydrochloride
Journal
Theriogenology
ISSN: 1879-3231
Titre abrégé: Theriogenology
Pays: United States
ID NLM: 0421510
Informations de publication
Date de publication:
01 Mar 2021
01 Mar 2021
Historique:
received:
08
10
2020
revised:
27
12
2020
accepted:
30
12
2020
pubmed:
15
1
2021
medline:
22
6
2021
entrez:
14
1
2021
Statut:
ppublish
Résumé
Oocyte in vitro maturation (IVM) is a crucial process that determines subsequent in vitro embryo production. The present study investigated the effects of the antioxidant tris (2-carboxyethyl) phosphine hydrochloride (TCEP-HCL) on the in vitro maturation of porcine oocytes and in vitro developmental competence of fertilized embryos. Oocytes were matured in IVM medium based on four concentration groups of TCEP-HCL (0, 50, 100, and 200 μM) treatment. 100 μM TCEP-HCL treatment significantly increased the oocyte first polar body extrusion rate, monospermy rate and subsequent in vitro fertilized embryo developmental capacity (cleavage rate, blastocyst formation rate, and blastocyst total cell number) compared to those in the control group. Furthermore, 100 μM TCEP-HCL treatment significantly reduced the levels of reactive oxygen species, significantly increased glutathione levels and mitochondrial content compared to those in the control group. Moreover, 100 μM TCEP-HCL treatment significantly decreased the oocyte apoptosis, blastocyst apoptosis compared to that in the controls. In summary, these results indicate that 100 μM TCEP-HCL treatment improves the quality and developmental capacity of in vitro-fertilized embryos by decreasing oxidative stress in porcine oocytes.
Identifiants
pubmed: 33444914
pii: S0093-691X(21)00007-8
doi: 10.1016/j.theriogenology.2020.12.027
pii:
doi:
Substances chimiques
Phosphines
0
phosphine
FW6947296I
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
32-41Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All the authors declare that there are no conflicts of interest.